Literature DB >> 33746944

Multi 'Omics Analysis of Intestinal Tissue in Ankylosing Spondylitis Identifies Alterations in the Tryptophan Metabolism Pathway.

Adam J Berlinberg1, Emilie H Regner2, Andrew Stahly1, Ana Brar3, Julie A Reisz4, Mark E Gerich2, Blair P Fennimore2, Frank I Scott2, Alison E Freeman2, Kristine A Kuhn1.   

Abstract

Intestinal microbial dysbiosis, intestinal inflammation, and Th17 immunity are all linked to the pathophysiology of spondyloarthritis (SpA); however, the mechanisms linking them remain unknown. One potential hypothesis suggests that the dysbiotic gut microbiome as a whole produces metabolites that influence human immune cells. To identify potential disease-relevant, microbiome-produced metabolites, we performed metabolomics screening and shotgun metagenomics on paired colon biopsies and fecal samples, respectively, from subjects with axial SpA (axSpA, N=21), Crohn's disease (CD, N=27), and Crohn's-axSpA overlap (CD-axSpA, N=12), as well as controls (HC, N=24). Using LC-MS based metabolomics of 4 non-inflamed pinch biopsies of the distal colon from subjects, we identified significant alterations in tryptophan pathway metabolites, including an expansion of indole-3-acetate (IAA) in axSpA and CD-axSpA compared to HC and CD and indole-3-acetaldehyde (I3Ald) in axSpA and CD-axSpA but not CD compared to HC, suggesting possible specificity to the development of axSpA. We then performed shotgun metagenomics of fecal samples to characterize gut microbial dysbiosis across these disease states. In spite of no significant differences in alpha-diversity among the 4 groups, our results confirmed differences in gene abundances of numerous enzymes involved in tryptophan metabolism. Specifically, gene abundance of indolepyruvate decarboxylase, which generates IAA and I3Ald, was significantly elevated in individuals with axSpA while gene abundances in HC demonstrated a propensity towards tryptophan synthesis. Such genetic changes were not observed in CD, again suggesting disease specificity for axSpA. Given the emerging role of tryptophan and its metabolites in immune function, altogether these data indicate that tryptophan metabolism into I3Ald and then IAA is one mechanism by which the gut microbiome potentially influences the development of axSpA.
Copyright © 2021 Berlinberg, Regner, Stahly, Brar, Reisz, Gerich, Fennimore, Scott, Freeman and Kuhn.

Entities:  

Keywords:  ankylosing spondylitis; indole; metabolomics; metagenomics; microbiome; spondyloarthritis; tryptophan

Mesh:

Substances:

Year:  2021        PMID: 33746944      PMCID: PMC7966505          DOI: 10.3389/fimmu.2021.587119

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  61 in total

Review 1.  Axial spondyloarthritis.

Authors:  Joachim Sieper; Denis Poddubnyy
Journal:  Lancet       Date:  2017-01-20       Impact factor: 79.321

2.  Integrated GC-MS and LC-MS plasma metabonomics analysis of ankylosing spondylitis.

Authors:  Peng Gao; Chen Lu; Fengxia Zhang; Ping Sang; Dawei Yang; Xiang Li; Hongwei Kong; Peiyuan Yin; Jing Tian; Xin Lu; Aiping Lu; Guowang Xu
Journal:  Analyst       Date:  2008-07-28       Impact factor: 4.616

3.  Perturbed Mucosal Immunity and Dysbiosis Accompany Clinical Disease in a Rat Model of Spondyloarthritis.

Authors:  Mark J Asquith; Patrick Stauffer; Sean Davin; Claire Mitchell; Phoebe Lin; James T Rosenbaum
Journal:  Arthritis Rheumatol       Date:  2016-09       Impact factor: 10.995

Review 4.  Indole as an intercellular signal in microbial communities.

Authors:  Jin-Hyung Lee; Jintae Lee
Journal:  FEMS Microbiol Rev       Date:  2009-12-15       Impact factor: 16.408

Review 5.  Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions.

Authors:  Linda S Zhang; Sean S Davies
Journal:  Genome Med       Date:  2016-04-21       Impact factor: 11.117

6.  Fecal metabolomics in pediatric spondyloarthritis implicate decreased metabolic diversity and altered tryptophan metabolism as pathogenic factors.

Authors:  M L Stoll; R Kumar; E J Lefkowitz; R Q Cron; C D Morrow; S Barnes
Journal:  Genes Immun       Date:  2016-10-27       Impact factor: 2.676

7.  Inter-niche and inter-individual variation in gut microbial community assessment using stool, rectal swab, and mucosal samples.

Authors:  Roshonda B Jones; Xiangzhu Zhu; Emili Moan; Harvey J Murff; Reid M Ness; Douglas L Seidner; Shan Sun; Chang Yu; Qi Dai; Anthony A Fodor; M Andrea Azcarate-Peril; Martha J Shrubsole
Journal:  Sci Rep       Date:  2018-03-07       Impact factor: 4.379

8.  Differences in the serum metabolome and lipidome identify potential biomarkers for seronegative rheumatoid arthritis versus psoriatic arthritis.

Authors:  Lilla Tóth; Rouven Behnisch; Margarida Souto-Carneiro; Konstantin Urbach; Karel D Klika; Rui A Carvalho; Hanns-Martin Lorenz
Journal:  Ann Rheum Dis       Date:  2020-02-20       Impact factor: 19.103

9.  Trimmomatic: a flexible trimmer for Illumina sequence data.

Authors:  Anthony M Bolger; Marc Lohse; Bjoern Usadel
Journal:  Bioinformatics       Date:  2014-04-01       Impact factor: 6.937

10.  Statistical evaluation of methods for identification of differentially abundant genes in comparative metagenomics.

Authors:  Viktor Jonsson; Tobias Österlund; Olle Nerman; Erik Kristiansson
Journal:  BMC Genomics       Date:  2016-01-25       Impact factor: 3.969

View more
  7 in total

1.  Microbiome, Transcriptome, and Metabolomic Analyses Revealed the Mechanism of Immune Response to Diarrhea in Rabbits Fed Antibiotic-Free Diets.

Authors:  Jie Wang; Huimei Fan; Siqi Xia; Jiahao Shao; Tao Tang; Li Chen; Xue Bai; Wenqiang Sun; Xianbo Jia; Shiyi Chen; Songjia Lai
Journal:  Front Microbiol       Date:  2022-07-06       Impact factor: 6.064

Review 2.  The arthritis connection to inflammatory bowel disease (IBD): why has it taken so long to understand it?

Authors:  Maedeh Ashrafi; Kristine A Kuhn; Michael H Weisman
Journal:  RMD Open       Date:  2021-04

Review 3.  The Role of the Microbiota in Graves' Disease and Graves' Orbitopathy.

Authors:  Jueyu Hou; Yunjing Tang; Yongjiang Chen; Danian Chen
Journal:  Front Cell Infect Microbiol       Date:  2021-12-22       Impact factor: 5.293

Review 4.  Metabolomics: An Emerging Approach to Understand Pathogenesis and to Assess Diagnosis and Response to Treatment in Spondyloarthritis.

Authors:  Chiara Rizzo; Federica Camarda; Denise Donzella; Lidia La Barbera; Giuliana Guggino
Journal:  Cells       Date:  2022-02-04       Impact factor: 6.600

Review 5.  The Potential Role of Genetics, Environmental Factors, and Gut Dysbiosis in the Aberrant Non-Coding RNA Expression to Mediate Inflammation and Osteoclastogenic/Osteogenic Differentiation in Ankylosing Spondylitis.

Authors:  Hsien-Tzung Liao; Chang-Youh Tsai; Chien-Chih Lai; Song-Chou Hsieh; Yi-Syuan Sun; Ko-Jen Li; Chieh-Yu Shen; Cheng-Han Wu; Cheng-Hsun Lu; Yu-Min Kuo; Tzu-Hao Li; Chung-Tei Chou; Chia-Li Yu
Journal:  Front Cell Dev Biol       Date:  2022-01-20

Review 6.  Metabolomic analysis in spondyloarthritis: A systematic review.

Authors:  Tianwen Huang; Yaoyu Pu; Xiangpeng Wang; Yanhong Li; Hang Yang; Yubin Luo; Yi Liu
Journal:  Front Microbiol       Date:  2022-09-02       Impact factor: 6.064

7.  Axial spondyloarthritis patients have altered mucosal IgA response to oral and fecal microbiota.

Authors:  Tejpal Gill; Patrick Stauffer; Mark Asquith; Ted Laderas; Tammy M Martin; Sean Davin; Matthew Schleisman; Claire Ramirez; Kimberly Ogle; Ingrid Lindquist; Justine Nguyen; Stephen R Planck; Carley Shaut; Sarah Diamond; James T Rosenbaum; Lisa Karstens
Journal:  Front Immunol       Date:  2022-09-28       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.